Canon Medical Systems announced today it received FDA 510(k) clearance for expanded capabilities with its Deep Learning Spectral CT.

Tustin, Calif.-based Canon’s Deep Learning Spectral CT’s expanded capabilities reach into cardiovascular applications now, according to a news release.

The CT is available on Canon’s Aquilion ONE/Prism Edition CT system, offering healthcare providers the ability to acquire whole-heart spectral images in one beat. The system includes a 16 cm-wide area detector, 0.275-second whole-heart acquisition capabilities and rapid kVp switching with deep learning spectral reconstruction.

Aquilion ONE/PRISM Edition integrates AI to offer conventional and spectral CT capabilities along with deep clinical insights to give physicians the means to make more informed decisions across the care continuum.

“By integrating AI into spectral imaging, Canon Medical is bringing innovative technology to the market that can make an immediate impact for clinicians, empowering them to make definitive diagnoses,” Canon Medical Systems USA managing director of the CT business unit Erin Angel said in the release. “With Deep Learning Spectral CT, we have leveraged the power of AI to overcome several of the barriers that are otherwise associated with dual energy and spectral imaging.”